Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EU Sites: Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) (FASTR-EU)

NCT06362668 is registered in ClinicalTrials.gov with Reprieve Cardiovascular, Inc as lead sponsor.

NCT NCT06362668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06362668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EU Sites: Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) (FASTR-EU)
Lead sponsor
Reprieve Cardiovascular, Inc
Phase
Not applicable
Overall status
Completed
Start date
May 17, 2024
Completion date
October 31, 2024
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure